These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 2463385)

  • 1. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.
    García-Barreno B; Palomo C; Peñas C; Delgado T; Perez-Breña P; Melero JA
    J Virol; 1989 Feb; 63(2):925-32. PubMed ID: 2463385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein.
    Robinson BS; Everson JS
    Arch Virol; 1992; 125(1-4):273-86. PubMed ID: 1379425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.
    Taylor G; Stott EJ; Furze J; Ford J; Sopp P
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2217-23. PubMed ID: 1383403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic structure of human respiratory syncytial virus fusion glycoprotein.
    López JA; Bustos R; Orvell C; Berois M; Arbiza J; García-Barreno B; Melero JA
    J Virol; 1998 Aug; 72(8):6922-8. PubMed ID: 9658147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.
    Murphy BR; Olmsted RA; Collins PL; Chanock RM; Prince GA
    J Virol; 1988 Oct; 62(10):3907-10. PubMed ID: 3047432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.
    Bourgeois C; Corvaisier C; Bour JB; Kohli E; Pothier P
    J Gen Virol; 1991 May; 72 ( Pt 5)():1051-8. PubMed ID: 2033389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.
    Walsh EE; Hall CB; Schlesinger JJ; Brandriss MW; Hildreth S; Paradiso P
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2953-61. PubMed ID: 2479715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.
    Anderson LJ; Hierholzer JC; Tsou C; Hendry RM; Fernie BF; Stone Y; McIntosh K
    J Infect Dis; 1985 Apr; 151(4):626-33. PubMed ID: 2579169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.
    Palomo C; García-Barreno B; Peñas C; Melero JA
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():669-75. PubMed ID: 2005433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.
    Palomo C; Albar JP; García-Barreno B; Melero JA
    J Virol; 1990 Sep; 64(9):4199-206. PubMed ID: 2384917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
    Martínez I; Dopazo J; Melero JA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
    Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
    Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic structure of the fusion glycoprotein of respiratory syncytial virus.
    Paradiso PR; Hu B; Hildreth S; Martin A; Arumugham R
    Adv Exp Med Biol; 1989; 251():273-8. PubMed ID: 2481965
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.
    van Wyke Coelingh K; Tierney EL
    J Virol; 1989 Jan; 63(1):375-82. PubMed ID: 2462062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
    Anderson K; Stott EJ; Wertz GW
    J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.
    Murphy BR; Walsh EE
    J Clin Microbiol; 1988 Aug; 26(8):1595-7. PubMed ID: 2459154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.